BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 24, 2008
View Archived Issues
Bendamustine-rituximab combination active in relapsed mantle cell and indolent B-cell lymphoma
Read More
Phase II study assesses dose titration, depression with intranasal antiobesity drug PYY-3-36
Read More
Novartis: Q3 review
Read More
Activity seen with OSI-930 in phase I study in solid tumor patients
Read More
Further Empatic clinical data show improved quality of life, early responses
Read More
Nefopam acts against shivering in healthy volunteers
Read More
Recent Tufts College and TransTech patents disclose novel antidiabetic agents
Read More
Recent Xenon, Merck Frosst and GSK patents impart novel analgesic agents
Read More
Novexel reports positive phase II NXL-103 results in adults with CAP
Read More
Newron reports positive safety and tolerability results for HF-0220 in AD
Read More
DUSA reports results for phase IIb Levulan PDT trial in acne
Read More
Schering-Plough updates recent pipeline and business developments
Read More
NMS and Genentech sign collaboration agreement for antibody drug conjugates in cancer
Read More
New drug delivery agents reported in recent Emisphere Technologies patent
Read More
FDA maintains clinical holds on two IND applications for Dynavax and Merck & Co.'s Heplisav
Read More
ViroPharma completes acquisiton of Lev Pharmaceuticals
Read More
Vernalis regains rights to portfolio of antiinflammatory compounds including V-85546
Read More
Glycotex initiates enrollment in phase IIb study of GLYC-101 in wound healing
Read More
ALK reports positive results from first follow-up year in GT-08 clinical study of Grazax
Read More
Vitae reacquires full rights to renin inhibitor program for hypertension from GSK
Read More
CytoDyn files new IND for proof-of-principle study to reconfirm dose range of Cytolin
Read More
Addrenex initiates phase II ADX-415 trial in hypertension
Read More
Medivir submits MAA to European regulatory authorities for Lipsovir
Read More
Opexa provides additional data for Tovaxin in multiple sclerosis
Read More
EMEA recommends temporary suspension of Acomplia marketing authorization in obese patients
Read More
